THEROX INFUSION GUIDEWIRES— 510(k) K971719

Substantially Equivalent

Therox, Inc.

FDA 510(k) clearance K971719 for THEROX INFUSION GUIDEWIRES, Substantially Equivalent on 1997-11-03. Applicant: Therox, Inc..

Clearance details

Applicant: Therox, Inc.
Product code: Code DQX
Advisory panel: Cardiovascular
Date received: 1997-05-09
Decision date: 1997-11-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Costa Mesa, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DQX

product code DQX

Death: 298
Injury: 4,385
Malfunction: 7,203
Other: 5
Total: 11,891

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.